Pharmacokinetic Study of Artemether-lumefantrine and Amodiaquine in Healthy Subjects

Stopped The decision was made due to the expired investigational drug and regulatory changes by the Thai FDA, along with increased importation costs. The research team and investigational drug sponsor agreed to seek approval for early project termination.

Conditions

• Pharmacokinetic
• Healthy
• Drug Combination

Interventions

• DRUG: Artemether-lumefantrine
• DRUG: Amodiaquine
• DRUG: Artemether-lumefantrine
• DRUG: Artemether-lumefantrine + Amodiaquine

Sponsor

University of Oxford

Collaborators

• [object Object]
• [object Object]